STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

HOOK HOOKIPA PHARMA INCORPORATED StockScouter® Report

4

StockScouter® Score

HOOKIPA PHARMA INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • One or more analysts has significantly increased quarterly earnings estimates for HOOK. Positive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • Two or more executives, directors or major shareholders sold a small number of shares recently. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

A
D
F
B

Previous Ratings

3
2